MEDICOX Co., Ltd. Logo

MEDICOX Co., Ltd.

Developing new drugs and building a distribution platform for healthcare solutions.

054180 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 도산대로 549 2~3층 (청담동, 블루펄빌딩), 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

MEDICOX Co., Ltd., formerly known as ChoongAng Ocean Co Ltd, has transitioned its business focus. The company's legacy operations involved the manufacture and sale of shipbuilding materials, specializing in producing blocks for vessel components like the bow, stern, propeller boss, and engine room. Following its name change, MEDICOX has pivoted towards the healthcare and pharmaceutical industry. Current strategic initiatives include new drug development and the establishment of a healthcare solutions distribution platform. The company aims to build a medical distribution network to create synergies with development and manufacturing partners in the healthcare sector.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for MEDICOX Co., Ltd. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-09-11 00:00
Pre-Annual General Meeting Information
주주총회소집결의 (임시주주총회)
Korean 6.4 KB
2025-09-11 00:00
Pre-Annual General Meeting Information
주주명부폐쇄기간또는기준일설정
Korean 4.4 KB
2025-09-02 00:00
Delisting Announcement
기타시장안내 (상장적격성 실질심사 대상 결정)
Korean 4.9 KB
2025-09-02 00:00
Delisting Announcement
주권매매거래정지기간변경 (상장적격성 실질심사 대상 결정)
Korean 4.7 KB
2025-08-29 00:00
Board/Management Information
대표이사변경
Korean 9.0 KB
2025-08-29 00:00
Board/Management Information
대표집행임원변경
Korean 9.1 KB
2025-08-26 00:00
Post-Annual General Meeting Information
임시주주총회결과
Korean 9.8 KB
2025-08-14 00:00
Audit Report / Information
반기검토(감사)의견부적정등사실확인(자본잠식률100분의50이상또는자기자본10억원미만포함)
Korean 12.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.5 MB
2025-08-11 00:00
Pre-Annual General Meeting Information
[기재정정]주주총회소집결의
Korean 15.1 KB
2025-08-11 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 92.1 KB
2025-08-11 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 63.3 KB

Automate Your Workflow. Get a real-time feed of all MEDICOX Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for MEDICOX Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
SoftOx Solutions AS Logo
Develops non-toxic, AMR-safe antimicrobials for wound care, disinfection & airway infections.
Norway SOFTX
Solasia Pharma K.K. Logo
In-licenses and commercializes oncology treatments and supportive care products in Asia.
Japan 4597
Sopharma AD Logo
Develops, manufactures, and distributes pharmaceuticals and generics in Bulgaria and regional markets.
Bulgaria SFA
Spago Nanomedical AB Logo
Developing nanomedicines for precise cancer diagnosis and targeted radionuclide therapy.
Sweden SPAGO
Spexis AG Logo
Clinical-stage biopharma developing macrocyclic therapeutics for rare diseases and oncology.
Switzerland SPEX
Sprint Bioscience Logo
Develops & out-licenses preclinical oncology drugs for difficult-to-treat cancers.
Sweden SPRINT
STADA Arzneimittel AG Logo
A leading European manufacturer of generics, consumer healthcare, and specialty pharmaceuticals.
Germany SAZ
Stayble Therapeutics AB Logo
Develops an injectable drug for lumbar disc herniation pain as an alternative to surgery.
Sweden STABL
STCUBE Logo
Develops first-in-class immunotherapies targeting BTN1A1 for treatment-resistant cancers.
South Korea 052020
STELLA PHARMA CORPORATION Logo
Develops boron drugs for Boron Neutron Capture Therapy (BNCT), a targeted cancer radiation treatment.
Japan 4888

Talk to a Data Expert

Have a question? We'll get back to you promptly.